CHICAGO, IL, Waltz Health, a provider of tools that help consumers make better-informed decisions on their prescriptions, launched with a $35 million Series A round of funding.
Waltz Health, a provider of tools that help consumers make better-informed decisions on their prescriptions. The company officially launched with a $35 million Series A round of funding.
Waltz Health's $35.4 million funding was led by GV, and included participation from Define Ventures, Echo Health Ventures, Blue Venture Fund, Byers Capital, and Twine Ventures. Other funding came from individual healthcare executives.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
